Αthanasios Kotsakis

5.1k total citations
166 papers, 3.6k citations indexed

About

Αthanasios Kotsakis is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Αthanasios Kotsakis has authored 166 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Oncology, 67 papers in Pulmonary and Respiratory Medicine and 37 papers in Molecular Biology. Recurrent topics in Αthanasios Kotsakis's work include Lung Cancer Treatments and Mutations (50 papers), Lung Cancer Research Studies (41 papers) and Cancer Cells and Metastasis (34 papers). Αthanasios Kotsakis is often cited by papers focused on Lung Cancer Treatments and Mutations (50 papers), Lung Cancer Research Studies (41 papers) and Cancer Cells and Metastasis (34 papers). Αthanasios Kotsakis collaborates with scholars based in Greece, United States and France. Αthanasios Kotsakis's co-authors include Vassilis Georgoulias, Filippos Koinis, Eleni‐Kyriaki Vetsika, Vassilis Georgoulias, Nikolaos Kentepozidis, Despoina Aggouraki, Athanassios Argiris, Sofia Agelaki, Stella Apostolaki and Dimitris Mavroudis and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Αthanasios Kotsakis

160 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Αthanasios Kotsakis Greece	35	2.5k	1.3k	1.0k	910	717	166	3.6k
Suxia Luo China	25	2.0k 0.8×	793 0.6×	1.3k 1.3×	745 0.8×	993 1.4×	108	3.5k
Sarah B. Goldberg United States	33	3.0k 1.2×	2.7k 2.1×	1.3k 1.2×	611 0.7×	495 0.7×	143	4.8k
Sigve Andersen Norway	33	2.0k 0.8×	1.2k 1.0×	1.6k 1.6×	1.4k 1.5×	981 1.4×	80	3.9k
Kathryn C. Arbour United States	21	2.5k 1.0×	1.8k 1.5×	1.3k 1.3×	747 0.8×	448 0.6×	53	3.8k
Marleen Kok Netherlands	30	2.3k 0.9×	817 0.6×	1.1k 1.1×	887 1.0×	953 1.3×	90	3.6k
Peter Vermeulen Belgium	35	2.3k 0.9×	776 0.6×	1.4k 1.4×	1.3k 1.4×	360 0.5×	79	4.0k
Chao Zhao China	34	2.3k 0.9×	2.0k 1.6×	1.1k 1.1×	1.0k 1.1×	479 0.7×	132	3.8k
Oronzo Brunetti Italy	35	1.5k 0.6×	525 0.4×	1.1k 1.1×	783 0.9×	692 1.0×	126	3.1k
Asim Amin United States	27	2.6k 1.0×	1.1k 0.9×	905 0.9×	431 0.5×	1.1k 1.5×	73	3.4k
Luis de la Cruz‐Merino Spain	26	2.6k 1.0×	703 0.6×	1.9k 1.9×	541 0.6×	812 1.1×	175	4.0k

Countries citing papers authored by Αthanasios Kotsakis

Since Specialization

Citations

This map shows the geographic impact of Αthanasios Kotsakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Αthanasios Kotsakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Αthanasios Kotsakis more than expected).

Fields of papers citing papers by Αthanasios Kotsakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Αthanasios Kotsakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Αthanasios Kotsakis. The network helps show where Αthanasios Kotsakis may publish in the future.

Co-authorship network of co-authors of Αthanasios Kotsakis

This figure shows the co-authorship network connecting the top 25 collaborators of Αthanasios Kotsakis. A scholar is included among the top collaborators of Αthanasios Kotsakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Αthanasios Kotsakis. Αthanasios Kotsakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Κοττέας, Ηλίας, Dimitra Stefanou, Helen Gogas, et al.. (2025). Real-world safety and efficacy of trastuzumab deruxtecan (T-DXd) in patients with HER2-positive/HER2-low metastatic breast cancer: a multicenter retrospective cohort study. Future Oncology. 21(24). 3189–3196. 1 indexed citations

Balgkouranidou, Ioanna, Eleni Κ. Efthimiadou, Vassilis Georgoulias, et al.. (2024). NALCN Promoter Methylation as a Biomarker for Metastatic Risk in a Cohort of Non-Small Cell Lung Cancer Patients. Biomolecules. 14(12). 1514–1514.

Vasilopoulos, Georgios, et al.. (2024). Injuries and Persistent Pain in Elite Adolescent Archery Athletes: A Cross-Sectional Epidemiological Study. Sports. 12(4). 101–101.

Tsapakidis, Konstantinos, et al.. (2024). ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment. Biomedicines. 12(1). 146–146. 5 indexed citations

Koinis, Filippos, Zafeiris Zafeiriou, Ippokratis Messaritakis, et al.. (2023). Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study. Cancers. 15(18). 4511–4511. 6 indexed citations

Nepka, Charitini�, et al.. (2023). Frontal Sinus Metastasis from Colonic Adenocarcinoma: a Case Report and Review of the Literature. Journal of Gastrointestinal Cancer. 54(4). 1356–1358. 1 indexed citations

Ju, Julia A., Athina Christopoulou, Vassilis Georgoulias, et al.. (2023). Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology. Cells. 12(15). 1940–1940. 5 indexed citations

Klinakis, Apostolos, Alexandra Voutsina, Κonstantinos Potaris, et al.. (2023). 1277P HRD status of patients with early stage non-small cell lung cancer. Annals of Oncology. 34. S737–S738. 1 indexed citations

Zarogoulidis, Paul, Wolfgang Hohenforst‐Schmidt, Wei Chen, et al.. (2023). Endobronchial Radiofrequency Ablation for pulmonary nodules with Radial-Ebus and Navigation: Pros and Cons. Journal of Cancer. 14(9). 1562–1570. 4 indexed citations

10.

Messaritakis, Ippokratis, Αthanasios Kotsakis, Saad Alkahtani, et al.. (2022). Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients. Journal of Personalized Medicine. 12(2). 154–154. 10 indexed citations

11.

Koinis, Filippos, et al.. (2022). Emerging Role of YAP and the Hippo Pathway in Prostate Cancer. Biomedicines. 10(11). 2834–2834. 8 indexed citations

12.

Markou, Athina, Eleni Tzanikou, Galatea Kallergi, et al.. (2021). Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer. Frontiers in Cell and Developmental Biology. 9. 641978–641978. 13 indexed citations

13.

Xenidis, Nikolaos, et al.. (2021). Circulating tumor cells as prognostic biomarkers in breast cancer: current status and future prospects. Expert Review of Molecular Diagnostics. 21(10). 1037–1048. 7 indexed citations

14.

Papadaki, Maria A., Ippokratis Messaritakis, Oraianthi Fiste, et al.. (2021). Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). International Journal of Molecular Sciences. 22(2). 925–925. 15 indexed citations

15.

Messaritakis, Ippokratis, Michail Nikolaou, Eleni Politaki, et al.. (2019). Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment. Lung Cancer. 135. 33–39. 33 indexed citations

16.

Kotsakis, Αthanasios, Samuel A. Yousem, & Shirish M. Gadgeel. (2010). Is Histologic Subtype Significant in the Management of NSCLC. 3(1). 4 indexed citations

17.

Kotsakis, Αthanasios & Taofeek K. Owonikoko. (2010). Targeting Angiogenesis in Non-Small Cell Lung Cancer (NSCLC). 3(1). 1 indexed citations

18.

Pallis, Athanasios, Sofia Agelaki, S. Kakolyris, et al.. (2008). Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy. Lung Cancer. 62(3). 356–363. 42 indexed citations

19.

Saridaki, Zacharenia, V. Bozionelou, Nikolaos Kentepozidis, et al.. (2007). A Dose Escalation Study of the Biweekly Administration of Paclitaxel, Oxaliplatin and Capecitabine in Patients with Advanced Solid Tumors. Oncology. 72(1-2). 45–50. 2 indexed citations

20.

Souglakos, John, Konstantinos Syrigos, Anna Potamianou, et al.. (2004). Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial. Annals of Oncology. 15(8). 1204–1209. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact